Data in Brief (Dec 2016)

Validation data supporting the characterization of novel copper complexes as anticancer agents

  • Ceyda Acilan,
  • Buse Cevatemre,
  • Zelal Adiguzel,
  • Didem Karakas,
  • Engin Ulukaya,
  • Nádia Ribeiro,
  • Isabel Correia,
  • João Costa Pessoa

DOI
https://doi.org/10.1016/j.dib.2016.11.063
Journal volume & issue
Vol. 9, no. C
pp. 1160 – 1174

Abstract

Read online

Three copper(II) complexes, Cu(Sal-Gly)(phen), Cu(Sal-Gly)pheamine, Cu(Sal-Gly)phepoxy were synthesized and characterized for their anticancer properties and mechanism of action (Acilan et al., in press) [1]. Here, we provide supporting data on colon cancer cell lines complementing our previous findings in cervix cells. This paper also contains a data table for the fold changes and p-values of all genes analyzed in this study via a custom RT-qPCR array. All compounds induced DNA damage (based on 8-oxo-guanidine, ɣH2AX staining in cells) and apoptosis (based on elevated DNA condensation/fragmentation, Annexin V staining, caspase 3/7 activity and mitochondrial membrane depolarization) in HCT-116 colon cancer cells. The increase in oxidative stress was also further confirmed in these cells. Further interpretation of the data presented here can be found in the article entitled “Synthesis, biological characterization and evaluation of molecular mechanisms of novel copper complexes as anticancer agents” (Acilan et al., in press) [1].